They played roles in mediating NSCLC cell proliferation, metastasis, and drug resistance by transactivating EGFR signaling [15, 24, 25], implying that the crosstalk between GPCR and EGFR may provide the opportunities to discover novel pharmacological approaches to treat lung cancer patients. This evidence concerns the gene EGFR and lung cancer.